Manzo Pharmaceut Total Asset vs. Current Asset
| MNZO Stock | USD 0.00001 0.00 0.00% |
Manzo Pharmaceut Total Assets |
|
For Manzo Pharmaceut profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Manzo Pharmaceut to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Manzo Pharmaceut utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Manzo Pharmaceut's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Manzo Pharmaceut over time as well as its relative position and ranking within its peers.
Manzo |
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Manzo Pharmaceut Current Asset vs. Total Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Manzo Pharmaceut's current stock value. Our valuation model uses many indicators to compare Manzo Pharmaceut value to that of its competitors to determine the firm's financial worth. Manzo Pharmaceut is considered to be number one stock in total asset category among its peers. It also is considered to be number one stock in current asset category among its peers fabricating about 0.08 of Current Asset per Total Asset. The ratio of Total Asset to Current Asset for Manzo Pharmaceut is roughly 12.83 . At this time, Manzo Pharmaceut's Total Assets are very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Manzo Pharmaceut's earnings, one of the primary drivers of an investment's value.Manzo Current Asset vs. Total Asset
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Manzo Pharmaceut |
| = | 192.41 K |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Manzo Pharmaceut |
| = | 15 K |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
Manzo Current Asset Comparison
Manzo Pharmaceut is currently under evaluation in current asset category among its peers.
Manzo Pharmaceut Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Manzo Pharmaceut, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Manzo Pharmaceut will eventually generate negative long term returns. The profitability progress is the general direction of Manzo Pharmaceut's change in net profit over the period of time. It can combine multiple indicators of Manzo Pharmaceut, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -41.7 K | -43.8 K | |
| Net Loss | -41.7 K | -43.8 K | |
| Income Before Tax | -41.7 K | -43.8 K | |
| Total Other Income Expense Net | -1.1 M | -1.2 M | |
| Net Loss | -41.7 K | -43.8 K | |
| Net Loss | -41.7 K | -43.8 K | |
| Change To Netincome | 280.8 K | 361.1 K |
Manzo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Manzo Pharmaceut. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Manzo Pharmaceut position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Manzo Pharmaceut's important profitability drivers and their relationship over time.
Use Manzo Pharmaceut in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Manzo Pharmaceut position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Manzo Pharmaceut will appreciate offsetting losses from the drop in the long position's value.Manzo Pharmaceut Pair Trading
Manzo Pharmaceut Pair Trading Analysis
The ability to find closely correlated positions to Manzo Pharmaceut could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Manzo Pharmaceut when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Manzo Pharmaceut - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Manzo Pharmaceut to buy it.
The correlation of Manzo Pharmaceut is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Manzo Pharmaceut moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Manzo Pharmaceut moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Manzo Pharmaceut can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Manzo Pharmaceut position
In addition to having Manzo Pharmaceut in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long Short Funds Thematic Idea Now
Long Short Funds
Funds or Etfs that are designed to hedge away market risk by investing in combination of bonds, stocks, derivative instruments as well as short positions to maximize returns irrespective of market conditions. The Long Short Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long Short Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
To fully project Manzo Pharmaceut's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Manzo Pharmaceut at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Manzo Pharmaceut's income statement, its balance sheet, and the statement of cash flows.